Dual Acid‐Responsive Micelle‐Forming Anticancer Polymers as New Anticancer Therapeutics
Source abstract
Abstract
Cinnamaldehyde, a major active compound of cinnamon, is known to induce apoptotic cell death in numerous human cancer cells. Here, dual acid‐responsive polymeric micelle‐forming cinnamaldehyde prodrugs, poly[(3‐phenylprop‐2‐ene‐1,1‐diyl)bis(oxy)bis(ethane‐2,1‐diyl)diacrylate]‐co‐4,4’(trimethylene dipiperidine)‐co‐poly(ethylene glycol), termed PCAE copolymers, are reported. PCAE is designed to incorporate cinnamaldehyde via acid‐cleavable acetal linkages in its pH‐sensitive hydrophobic backbone and self assemble to form stable micelles which can encapsulate camptothecin (CPT). PCAE self assembles to form micelles which release CPT and cinnamaldehyde in pH‐dependent manners. PCAE micelles induce apoptotic cell death through the generation of intracellular reactive oxygen species (ROS) and exert synergistic anticancer effects with a payload of CPT in vitro and in vivo model of SW620 human colon tumor‐bearing mice. It is anticipated that dual acid‐sensitive micelle‐forming PCAE with intrinsic anticancer activities has enormous potential as novel anticancer therapeutics.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of BIN Fusion Technology Chonbuk National University Jeonju Chonbuk 561‐756 Korea
Polymer Fusion Research Center, Department of Polymer·Nano Science and Technology Chonbuk National University Jeonju Chonbuk 561‐756 Korea
References (32)
Show source-provided references
1. 10.1016/j.tibtech.2005.11.00610.1016/j.tibtech.2005.11.006 ↗
2. 10.1007/s11095-010-0233-410.1007/s11095-010-0233-4 ↗
3. 10.1074/jbc.M30970820010.1074/jbc.M309708200 ↗
4. Palmer H. J. · Nat. Rev. · 1997 · 55 · 353
5. 10.1016/S0003-9861(02)00053-X10.1016/S0003-9861(02)00053-X ↗
6. 10.1016/S0014-5793(98)01410-010.1016/S0014-5793(98)01410-0 ↗
7. 10.1074/jbc.273.41.2690010.1074/jbc.273.41.26900 ↗
8. 10.1023/A:100961622830410.1023/A:1009616228304 ↗
9. 10.1016/j.freeradbiomed.2008.10.02510.1016/j.freeradbiomed.2008.10.025 ↗
10. 10.1016/j.freeradbiomed.2009.10.02810.1016/j.freeradbiomed.2009.10.028 ↗
11. 10.1016/j.bbrc.2009.07.10410.1016/j.bbrc.2009.07.104 ↗
12. 10.1016/j.foodchem.2006.08.01810.1016/j.foodchem.2006.08.018 ↗
13. 10.1016/S0304-3835(03)00238-610.1016/S0304-3835(03)00238-6 ↗
14. 10.1016/j.addr.2004.10.00610.1016/j.addr.2004.10.006 ↗
15. 10.1080/0049825080265006910.1080/00498250802650069 ↗
16. 10.1016/S0142-9612(00)00073-910.1016/S0142-9612(00)00073-9 ↗
17. 10.1002/marc.20090002910.1002/marc.200900029 ↗
18. 10.1002/adfm.20090083910.1002/adfm.200900839 ↗
19. 10.1021/nn100968e10.1021/nn100968e ↗
20. 10.1039/c0cc01413c10.1039/c0cc01413c ↗
21. 10.1021/ja001538810.1021/ja0015388 ↗
22. 10.1039/B304251K10.1039/B304251K ↗
23. 10.1073/pnas.093064410010.1073/pnas.0930644100 ↗
24. 10.1021/ma00125a04010.1021/ma00125a040 ↗
25. 10.1002/adfm.20060081810.1002/adfm.200600818 ↗
26. 10.1016/j.jconrel.2007.07.01210.1016/j.jconrel.2007.07.012 ↗
27. 10.1016/j.jconrel.2010.02.02410.1016/j.jconrel.2010.02.024 ↗
28. 10.1016/j.biomaterials.2010.11.03310.1016/j.biomaterials.2010.11.033 ↗
29. 10.1038/sj.cdd.440143510.1038/sj.cdd.4401435 ↗
30. 10.1016/j.ejpb.2010.04.01710.1016/j.ejpb.2010.04.017 ↗
31. 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R ↗
32. 10.1158/1078-0432.CCR-06-078610.1158/1078-0432.CCR-06-0786 ↗